| scholarly article | Q13442814 |
| P50 | author | Cedric Prys-Roberts | Q54862551 |
| P2093 | author name string | Willatts SM | |
| Kong KL | |||
| P2860 | cites work | Morphine intoxication in renal failure: the role of morphine-6-glucuronide | Q24537958 |
| APACHE II: a severity of disease classification system | Q29547729 | ||
| Propofol infusion for sedation in the intensive care unit: preliminary report. | Q34068618 | ||
| Prolonged midazolam elimination half-life | Q43240399 | ||
| Effect of Morphine on Resistance to Infection | Q44014937 | ||
| Profound reduction in morphine clearance and liver blood flow in shock | Q44302503 | ||
| The effects of midazolam reversal by RO 15-1788 on cerebral perfusion pressure in patients with severe head injury | Q46221901 | ||
| Alfentanil infusions on the intensive therapy unit | Q51778372 | ||
| Propofol infusion for sedation in intensive care | Q51785968 | ||
| Failure of critically ill patients to metabolise midazolam | Q51789578 | ||
| Assessment of alfentanil by intravenous infusion as long-term sedation in intensive care | Q51791750 | ||
| Comparison of infusions of alfentanil or pethidine for sedation of ventilated patients on the ITU. | Q51803187 | ||
| Age and nature of operation influence the pharmacokinetics of midazolam | Q51822924 | ||
| Intracranial pressure after phenoperidine | Q51842400 | ||
| Treatment of sympathetic overactivity in tetanus | Q52747886 | ||
| Controlled Sedation with Alphaxalone-Alphadolone | Q55061590 | ||
| Influence of bolus doses of phenoperidine on intracranial pressure and systemic arterial pressure in traumatic coma | Q68956292 | ||
| Sedation in intensive care--a postal survey | Q69026819 | ||
| P433 | issue | 6683 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | isoflurane | Q413918 |
| midazolam | Q423071 | ||
| intensive care unit | Q5094647 | ||
| P1104 | number of pages | 4 | |
| P304 | page(s) | 1277-1280 | |
| P577 | publication date | 1989-05-01 | |
| P1433 | published in | The BMJ | Q546003 |
| P1476 | title | Isoflurane compared with midazolam for sedation in the intensive care unit | |
| P478 | volume | 298 |
| Q41960498 | A novel device for target controlled administration and reflection of desflurane--the Mirus™. |
| Q24794122 | A prospective randomised pilot study of sedation regimens in a general ICU population: a reality-based medicine study |
| Q48127651 | A technical review of the history, development and performance of the anaesthetic conserving device "AnaConDa" for delivering volatile anaesthetic in intensive and post-operative critical care. |
| Q41722340 | Adverse Responses to Analgesia, Sedation, and Neuromuscular Blocking Agents in Infants and Children |
| Q82305692 | Anesthetic conserving device (AnaConDa) used after cardiac surgery: experience in a postoperative recovery unit |
| Q38007630 | Assisted ventilation. 2. Indications for mechanical ventilation |
| Q37832145 | Assisted ventilation. 3. General care of the ventilated patient in the intensive care unit |
| Q51748854 | Comparison of propofol and midazolam for sedation in critically ill patients |
| Q33696421 | Evidence and consensus-based German guidelines for the management of analgesia, sedation and delirium in intensive care--short version |
| Q42874091 | Functioning of the anaesthetic conserving device: aspects to consider for use in inhalational sedation |
| Q37621086 | Inhalational anesthesia: basic pharmacology, end organ effects, and applications in the treatment of status asthmaticus |
| Q47257594 | Inhaled anesthetic agent sedation in the ICU and trace gas concentrations: a review |
| Q51567137 | Inorganic fluoride concentration after long-term sedation with isoflurane |
| Q51600188 | Isoflurane Sedation in Pediatric Intensive Care |
| Q42879448 | Isoflurane compared with midazolam in the intensive care unit |
| Q43044838 | Isoflurane compared with midazolam in the intensive care unit |
| Q43300764 | Isoflurane compared with midazolam in the intensive care unit |
| Q51700074 | Isoflurane for prolonged sedation in the intensive care unit; efficacy and safety |
| Q36928217 | Late pharmacologic conditioning with volatile anesthetics after cardiac surgery |
| Q48275971 | Long-term sedation in intensive care unit: a randomized comparison between inhaled sevoflurane and intravenous propofol or midazolam |
| Q37169834 | Medications for analgesia and sedation in the intensive care unit: an overview |
| Q46888197 | Minimum alveolar concentration (MAC) for sevoflurane and xenon at normothermia and hypothermia in newborn pigs |
| Q36289585 | Monitoring sedation levels by EEG spectral analysis. |
| Q40645816 | Pain management and sedation in the pediatric intensive care unit. |
| Q39468816 | Pain relief following cardiac surgery: a review |
| Q40815584 | Pharmacokinetics and pharmacodynamics in the critically ill patient |
| Q48214886 | Pharmacology of Sedative-Analgesic Agents: Dexmedetomidine, Remifentanil, Ketamine, Volatile Anesthetics, and the Role of Peripheral Mu Antagonists |
| Q51530486 | Prolonged Administration of Isoflurane to Patients with Severe Renal Dysfunction |
| Q37948029 | Sedation and Analgesia in the Mechanically Ventilated Patient |
| Q33999081 | Sedation and analgesia in paediatric intensive care units: a guide to drug selection and use. |
| Q30319372 | Sedation concepts with volatile anaesthetics in intensive care: practical use and current experiences with the AnaConDa system |
| Q38040844 | Sedation for critically ill or injured adults in the intensive care unit: a shifting paradigm |
| Q36429872 | Sedation in the intensive care setting |
| Q30467919 | Sedation of the agitated, critically ill patient without an artificial airway. |
| Q39474617 | The Use of Continuous IV Sedation Is Associated With Prolongation of Mechanical Ventilation |
| Q46057084 | The scavenging of volatile anesthetic agents in the cardiovascular intensive care unit environment: a technical report. |
| Q36505753 | The social and economic impact of salmonellosis. A report of a national survey in England and Wales of laboratory-confirmed Salmonella infections |
| Q35323911 | The use of sedative agents in critically ill patients |
| Q47235617 | Toxicity of inhaled agents after prolonged administration |
| Q46678278 | Use of dexmedetomidine in a pediatric heart transplant patient |
| Q34474073 | Using protocols to improve the outcomes of mechanically ventilated patients. Focus on weaning and sedation |
| Q38784583 | Volatile Anesthetics. Is a New Player Emerging in Critical Care Sedation? |
| Q89909647 | [New technical developments for inhaled sedation] |
Search more.